This company has been acquired
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Apollo Endosurgery Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Anahtar bilgiler
164.7%
Borç/özkaynak oranı
US$53.68m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | US$57.00m |
| Eşitlik | US$32.59m |
| Toplam yükümlülükler | US$77.64m |
| Toplam varlıklar | US$110.23m |
Son finansal sağlık güncellemeleri
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?
Aug 05Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Mar 02Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?
May 05We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt
Jan 31Recent updates
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?
Aug 05Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings
Aug 04Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Mar 02Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?
Aug 04Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy
Jun 28Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?
May 05Apollo Endosurgery EPS beats by $0.05, beats on revenue
May 04A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)
Mar 24What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?
Mar 03Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares
Feb 10We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt
Jan 31Assessing Apollo Endosurgery
Dec 27If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%
Dec 27Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?
Dec 01Apollo Endosurgery EPS beats by $0.10, beats on revenue
Nov 05Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: APEN's short term assets ($92.9M) exceed its short term liabilities ($39.5M).
Uzun Vadeli Yükümlülükler: APEN's short term assets ($92.9M) exceed its long term liabilities ($38.1M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: APEN has more cash than its total debt.
Borcun Azaltılması: APEN's debt to equity ratio has increased from 66.8% to 164.7% over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: APEN has sufficient cash runway for more than a year based on its current free cash flow.
Tahmini Nakit Akışı: APEN has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 5% each year.